213 related articles for article (PubMed ID: 30128035)
1. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
[TBL] [Abstract][Full Text] [Related]
2. LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.
Xiang S; Gu H; Jin L; Thorne RF; Zhang XD; Wu M
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1465-E1474. PubMed ID: 29378948
[TBL] [Abstract][Full Text] [Related]
3. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
[TBL] [Abstract][Full Text] [Related]
4. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
[TBL] [Abstract][Full Text] [Related]
5. TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.
Liu W; Chen X; He Y; Tian Y; Xu L; Ma Y; Hu P; Su K; Luo Z; Wei L; Zhang J
Oncol Rep; 2019 Apr; 41(4):2418-2430. PubMed ID: 30816548
[TBL] [Abstract][Full Text] [Related]
6. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.
Li J; Zhang J; Xie F; Peng J; Wu X
Int J Mol Med; 2018 Feb; 41(2):1062-1068. PubMed ID: 29207023
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
Li Y; Zhao L; Qi Y; Yang X
Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells.
Tanaka H; Sasayama T; Tanaka K; Nakamizo S; Nishihara M; Mizukawa K; Kohta M; Koyama J; Miyake S; Taniguchi M; Hosoda K; Kohmura E
J Neurooncol; 2013 Feb; 111(3):273-83. PubMed ID: 23263745
[TBL] [Abstract][Full Text] [Related]
10. Lithium chloride decreases proliferation and migration of C6 glioma cells harboring isocitrate dehydrogenase 2 mutant via GSK-3β.
Fu Y; Zheng Y; Chan KG; Liang A; Hu F
Mol Biol Rep; 2014 Jun; 41(6):3907-13. PubMed ID: 24549719
[TBL] [Abstract][Full Text] [Related]
11. SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth.
Zou X; Zhu Y; Park SH; Liu G; O'Brien J; Jiang H; Gius D
Cancer Res; 2017 Aug; 77(15):3990-3999. PubMed ID: 28536275
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants.
Gao M; Zhu H; Fu L; Li Y; Bao X; Fu H; Quan H; Wang L; Lou L
Cancer Sci; 2019 Oct; 110(10):3306-3314. PubMed ID: 31361380
[TBL] [Abstract][Full Text] [Related]
13. A new functional IDH2 genetic variant is associated with the risk of lung cancer.
Li J; Lu J; He Y; Wu Y; Wu Y; Song X; Jiang Y; Tang M; Weng X; Yi W; Luo X; Sun L; Bode AM; Cao Y
Mol Carcinog; 2017 Mar; 56(3):1082-1087. PubMed ID: 27649069
[TBL] [Abstract][Full Text] [Related]
14. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
[TBL] [Abstract][Full Text] [Related]
15. The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.
Ward PS; Lu C; Cross JR; Abdel-Wahab O; Levine RL; Schwartz GK; Thompson CB
J Biol Chem; 2013 Feb; 288(6):3804-15. PubMed ID: 23264629
[TBL] [Abstract][Full Text] [Related]
16. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.
Lin AP; Abbas S; Kim SW; Ortega M; Bouamar H; Escobedo Y; Varadarajan P; Qin Y; Sudderth J; Schulz E; Deutsch A; Mohan S; Ulz P; Neumeister P; Rakheja D; Gao X; Hinck A; Weintraub ST; DeBerardinis RJ; Sill H; Dahia PL; Aguiar RC
Nat Commun; 2015 Jul; 6():7768. PubMed ID: 26178471
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the gene encoding the IDH1 subunit of NAD(+)-dependent isocitrate dehydrogenase from Saccharomyces cerevisiae.
Cupp JR; McAlister-Henn L
J Biol Chem; 1992 Aug; 267(23):16417-23. PubMed ID: 1644826
[TBL] [Abstract][Full Text] [Related]
19. Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism.
Li H; Li JJ; Lu W; Yang J; Xia Y; Huang P
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831011
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of NAD(+)-isocitrate dehydrogenase with altered isocitrate binding sites: contribution of IDH1 and IDH2 subunits to regulation and catalysis.
Cupp JR; McAlister-Henn L
Biochemistry; 1993 Sep; 32(36):9323-8. PubMed ID: 8369302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
